Search - tctmd.com

Displaying 261 - 280 of 353

Sort: Relevancy | Date

News Conference News EAS 2025

Back From the Brink: Obicetrapib Performs Well in BROADWAY, TANDEM

Yael L. Maxwell

May 08, 2025

News Daily News

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

Michael O'Riordan

May 07, 2025

News Daily News

Lp(a) Genetics Differ Between Populations but Have Similar Clinical Impact

Yael L. Maxwell

May 05, 2025

News Daily News

Donor Hearts Fare Better With Novel Method After Circulatory Death

Michael O'Riordan

May 01, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2025

Caitlin E. Cox

April 30, 2025

Podcast Heart Sounds

Top Cardiology News for April 2025

April 30, 2025

News Daily News

Lorundrostat Lowers BP in Treatment-Resistant Hypertension: Advance-HTN

Yael L. Maxwell

April 29, 2025

News Conference News HRS 2025

VANISH2 Bolsters Data Backing VT Ablation in Ischemic Cardiomyopathy

Todd Neale

April 29, 2025

News Conference News CX Symposium 2025

Plant-Derived Compound Shows Early Promise for Small AAAs

L.A. McKeown

April 25, 2025

News Daily News

LuX-Valve TTVR Device Provides Favorable 1-Year Results

Yael L. Maxwell

April 24, 2025

News Conference News CX Symposium 2025

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

L.A. McKeown

April 24, 2025

News Daily News

PFO, Risk Factors Both Exert Influence in Younger Cryptogenic Stroke Patients

Todd Neale

April 23, 2025

News Daily News

Oral GLP-1 Drug Shines in Phase III ACHIEVE-1 Trial, Lilly Says

Caitlin E. Cox

April 17, 2025

News Featured Fellow

Aditya Mehta, MBBS

Yael L. Maxwell

April 10, 2025

News Conference News ACC 2025

ALPACA: Injectable siRNA Agent Safe and Effective for Lowering Lp(a)

L.A. McKeown

April 10, 2025

News Daily News

FDA Drops REMS Requirement for Antihypertensive Aprocitentan

Michael O'Riordan

April 09, 2025

News Conference News EHRA 2025

Post-TAVI Pacemaker Tied to Poorer Long-term Outcomes

Todd Neale

April 08, 2025

News Conference News ACC 2025

AI Shows Promise in Detecting Type 1 MI and Need for Revascularization

Yael L. Maxwell

April 07, 2025

News Conference News ACC 2025

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

Michael O'Riordan

March 29, 2025

News Daily News ACC 2025

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

L.A. McKeown

March 29, 2025

Advertisement

Back From the Brink: Obicetrapib Performs Well in BROADWAY, TANDEM

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

Lp(a) Genetics Differ Between Populations but Have Similar Clinical Impact

Donor Hearts Fare Better With Novel Method After Circulatory Death

TCTMD’s Top 10 Most Popular Stories for April 2025

Top Cardiology News for April 2025

Lorundrostat Lowers BP in Treatment-Resistant Hypertension: Advance-HTN

VANISH2 Bolsters Data Backing VT Ablation in Ischemic Cardiomyopathy

Plant-Derived Compound Shows Early Promise for Small AAAs

LuX-Valve TTVR Device Provides Favorable 1-Year Results

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

PFO, Risk Factors Both Exert Influence in Younger Cryptogenic Stroke Patients

Oral GLP-1 Drug Shines in Phase III ACHIEVE-1 Trial, Lilly Says

Aditya Mehta, MBBS

ALPACA: Injectable siRNA Agent Safe and Effective for Lowering Lp(a)

FDA Drops REMS Requirement for Antihypertensive Aprocitentan

Post-TAVI Pacemaker Tied to Poorer Long-term Outcomes

AI Shows Promise in Detecting Type 1 MI and Need for Revascularization

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content